SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-18-020076
Filing Date
2018-11-08
Accepted
2018-11-08 16:12:00
Documents
22
Period of Report
2018-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K kmph20181024_8k.htm 8-K 25567
2 EXHIBIT 99.1 ex_126198.htm EX-99.1 176801
3 EXHIBIT 99.2 ex_126199.htm EX-99.2 10265
4 slide17.jpg GRAPHIC 284657
5 slide16.jpg GRAPHIC 207511
6 slide15.jpg GRAPHIC 365395
7 slide14.jpg GRAPHIC 247990
8 slide13.jpg GRAPHIC 207136
9 slide12.jpg GRAPHIC 263008
10 slide11.jpg GRAPHIC 295201
11 slide10.jpg GRAPHIC 354585
12 slide09.jpg GRAPHIC 299974
13 slide08.jpg GRAPHIC 355189
14 slide07.jpg GRAPHIC 363298
15 slide06.jpg GRAPHIC 250585
16 slide05.jpg GRAPHIC 189290
17 slide04.jpg GRAPHIC 292281
18 slide03.jpg GRAPHIC 105794
19 slide02.jpg GRAPHIC 466919
20 slide01.jpg GRAPHIC 90189
21 ex99-1img002.jpg GRAPHIC 3740
22 ex99-1img001.jpg GRAPHIC 2054
  Complete submission text file 0001437749-18-020076.txt   6594761
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36913 | Film No.: 181169803
SIC: 2834 Pharmaceutical Preparations